Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin alpha-1C chain (TUBA1C) is a protein that forms part of the microtubule cytoskeleton as a major component of the alpha/beta-tubulin heterodimer[1][4]. Microtubules are essential for cellular structure, organelle and vesicle trafficking, and force generation in cell division[2]. TUBA1C is highly conserved and plays critical roles in organizing the microtubule network, especially during mitosis and cell differentiation[1][2]. Alterations in tubulin isotype expression, including TUBA1C, have been associated with cancer development, chemotherapy resistance, and neurodevelopmental disorders[2][7]. Drugs targeting microtubules, such as taxanes and vinca alkaloids, interact with tubulin to inhibit proper microtubule function, thus blocking cell division particularly in rapidly dividing tumor cells[2]. Therapeutic targeting of tubulin is complicated by potential neurotoxicity and emergence of drug resistance related to isotype composition or mutation[2].
Disruption of microtubule dynamics (stabilization or destabilization), interfering with cell division; Induction of mitotic arrest and apoptosis in dividing cells
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin alpha-1C chain (TUBA1C).